Nafarelin for Treatment of Endometriosis

Michael Peter Diamond, Alan H. Decherney, Milan R. Henzl, Stephen L. Corson, Kamran Moghissi, Veasy C. Buttram, Christer Berqvist, Jan Jacobson

Research output: Contribution to journalLetter

1 Scopus citations

Abstract

To the Editor: Henzl et al. (Feb. 25 issue)1 report on a multicenter double-blind comparative clinical trial of nafarelin and danazol for the treatment of endometriosis. The study design used preoperative laparoscopy to assess the initial extent of disease and a second-look laparoscopic examination to assess the extent of residual endometriosis. As would be expected, therapy with either nafarelin or danazol resulted in a significant reduction in the endometriosis score as calculated with use of the American Fertility Society's classification system. An unexpected finding, and one not commented on by the authors, was the significant reduction in adhesion scores in.

Original languageEnglish (US)
Pages (from-to)519-520
Number of pages2
JournalNew England Journal of Medicine
Volume319
Issue number8
DOIs
StatePublished - Aug 25 1988
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Diamond, M. P., Decherney, A. H., Henzl, M. R., Corson, S. L., Moghissi, K., Buttram, V. C., Berqvist, C., & Jacobson, J. (1988). Nafarelin for Treatment of Endometriosis. New England Journal of Medicine, 319(8), 519-520. https://doi.org/10.1056/NEJM198808253190814